We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.35 | 0.26% | 133.27 | 2,539 | 09:22:00 |
From May 2019 to May 2024
By Sven Grundberg
STOCKHOLM--Insulin maker Novo Nordisk A/S (NOVO-B.KO) Friday said it has been served with a subpoena by a U.S. Attorney requesting documents regarding potential manufacturing issues within its Danish production units.
The Danish company said the subpoena was filed by the the US Attorney for the District of Massachusetts and related to its manufacturing in Kalundborg, Denmark.
The company added that it is cooperating with the attorney in the investigation and that it can't predict the outcome of the matter or assess its possible consequences.
-Write to Sven Grundberg at sven.grundberg@wsj.com; Twitter: @WSJNordics
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
